Capital One Initiates Coverage On GlycoMimetics with Overweight Rating, Announces Price Target of $12
Portfolio Pulse from Benzinga Newsdesk
Capital One analyst Zegbeh Jallah has initiated coverage on GlycoMimetics (NASDAQ:GLYC) with an Overweight rating and set a price target of $12.

December 22, 2023 | 12:09 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Capital One analyst Zegbeh Jallah initiated coverage on GlycoMimetics with an Overweight rating and a price target of $12.
The initiation of coverage by Capital One with an Overweight rating typically indicates a positive outlook on the stock, suggesting that the analyst believes it will outperform the market or its sector. The announcement of a price target of $12, which is presumably higher than the current trading price, is likely to be viewed as a bullish signal by investors, potentially driving short-term interest and an increase in the stock price.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100